Injury-Induced Interleukin-1 Alpha Promotes Lgr5 Hair Follicle Stem Cells Regeneration and Proliferation via Regulating Regenerative Microenvironment in Mice

PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.

NMN shows promise in promoting hair growth by reducing oxidative stress and weakening androgens. It may be a beneficial addition to hair loss treatments like Minoxidil and Finasteride.

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

The user is disappointed with the lack of visible progress in hair regrowth after 6 months of using finasteride and minoxidil. Another user suggests adding a topical anti-androgen like kx826, while encouraging patience as changes may start to show between 6-9 months.

The user experienced significant hair regrowth using 1+ mg of finasteride and 2.5 mg of minoxidil, later increasing to 5 mg, along with dermarolling. They reported no negative side effects and noted improved libido.

Stopping Dutasteride may temporarily affect sperm quality, but it typically returns to normal within a few months. Minoxidil and Dutasteride are used for hair maintenance, and Mucuna Pruriens and hCG are suggested for improving sperm quality.